Gvoke hypopen 2-PK 1 MG/0.2 ML 0.2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FWHK6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,111
Award facts
- Contract value 100% obligated
- $2,111.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 13, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Gvoke HypenPen 2-pack auto-injectors (1 mg/0.2 ml dosage) valued at $2,111.40 with a completion date of January 14, 2026. The award is non-set-aside and structured as a firm fixed-price delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. This contract vehicle, valued at up to $999,999,999.00 and running through December 2026, serves as a comprehensive global pharmaceutical supply mechanism enabling AmerisourceBergen to distribute a wide range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs and the Defense Health Agency.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC with DLA and competes on a full and open basis for federal contracts. The delivery of Gvoke HypenPen auto-injectors—used for emergency glucagon injection in hypoglycemic episodes—represents part of the company's extensive portfolio supplying diabetes management medications and specialized medical devices across the federal healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FWHK6?
SPE2DR26FWHK6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FWHK6 worth?
The government has obligated $2,111 on SPE2DR26FWHK6.
Is contract SPE2DR26FWHK6 an order under another contract?
Yes. SPE2DR26FWHK6 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWHK6 competed?
The extent of competition for SPE2DR26FWHK6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award